Global Neuroendocrine Carcinoma Treatment Market Size, Share, and COVID-19 Impact Analysis, By Indication Type (Gastric Neuroendocrine Tumor, Lung Neuroendocrine Tumors, Pancreatic Neuroendocrine Tumors, and Appendiceal Neuroendocrine Tumors), By Treatment Type (Chemotherapy, Antimetabolites, Alkylating agents, Natural Products, Targeted Therapy, Tyrosine Kinase Inhibitor, mTOR Inhibitor, and Somatostatin Analogs), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035
Premium Report Details
Base Year:
2024
Tables & Figures:
124
Pages:
245
Countries covered:
17
Companies covered::
20
Forecast CAGR:
8.09%
Connect with us
smartphone
smartphone
email
email
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we
also
use cookies to show you personalized ads? Learn
more and manage your cookies